Valeant Pharmaceuticals International, Inc. (TSE:VRX – Get Free Report) (NYSE:VRX) shares fell 3.3% during mid-day trading on Monday . The company traded as low as C$30.75 and last traded at C$30.80. 1,232,408 shares changed hands during mid-day trading, a decline of 11% from the average session volume of 1,382,994 shares. The stock had previously closed at C$31.86.
Valeant Pharmaceuticals International Price Performance
The company’s 50-day moving average is C$30.80.
Valeant Pharmaceuticals International Company Profile
Valeant Pharmaceuticals International, Inc operates as a multinational, specialty pharmaceutical, and medical device company that develops, manufactures, and markets a range of pharmaceuticals, over-the-counter (OTC) products, and medical devices. The company operates through three segments: Bausch + Lomb/International, Branded Rx, and U.S.
See Also
- Five stocks we like better than Valeant Pharmaceuticals International
- How to Evaluate a Stock Before Buying
- This Stock’s Price Shifts Into High Gear With Analyst Upgrades
- Financial Services Stocks Investing
- AI Boosts Glass Tech Leader Stock: Shares Up 75% and More to Come
- How to Use High Beta Stocks to Maximize Your Investing Profits
- AI Partnership Boosts This Top Tech Stock: Ready for More Gains?
Receive News & Ratings for Valeant Pharmaceuticals International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeant Pharmaceuticals International and related companies with MarketBeat.com's FREE daily email newsletter.